Mithra Pharmaceuticals SA

ENXTBR:MITRA Voorraadrapport

Marktkapitalisatie: €12.1m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Mithra Pharmaceuticals Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Christophe Marechal

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO7.6yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijn4.4yrs
Gemiddelde ambtstermijn bestuur2.8yrs

Recente managementupdates

Recent updates

Not Many Are Piling Into Mithra Pharmaceuticals SA (EBR:MITRA) Stock Yet As It Plummets 26%

Apr 06
Not Many Are Piling Into Mithra Pharmaceuticals SA (EBR:MITRA) Stock Yet As It Plummets 26%

Revenues Working Against Mithra Pharmaceuticals SA's (EBR:MITRA) Share Price Following 39% Dive

Feb 07
Revenues Working Against Mithra Pharmaceuticals SA's (EBR:MITRA) Share Price Following 39% Dive

Party Time: Brokers Just Made Major Increases To Their Mithra Pharmaceuticals SA (EBR:MITRA) Earnings Forecasts

Nov 09
Party Time: Brokers Just Made Major Increases To Their Mithra Pharmaceuticals SA (EBR:MITRA) Earnings Forecasts

These Analysts Just Made A Huge Downgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) EPS Forecasts

Oct 05
These Analysts Just Made A Huge Downgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) EPS Forecasts

Take Care Before Diving Into The Deep End On Mithra Pharmaceuticals SA (EBR:MITRA)

May 23
Take Care Before Diving Into The Deep End On Mithra Pharmaceuticals SA (EBR:MITRA)

Bullish: Analysts Just Made A Huge Upgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) Forecasts

Aug 11
Bullish: Analysts Just Made A Huge Upgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) Forecasts

Growth Investors: Industry Analysts Just Upgraded Their Mithra Pharmaceuticals SA (EBR:MITRA) Revenue Forecasts By 21%

Mar 13
Growth Investors: Industry Analysts Just Upgraded Their Mithra Pharmaceuticals SA (EBR:MITRA) Revenue Forecasts By 21%

Mithra Pharmaceuticals (EBR:MITRA) Is Making Moderate Use Of Debt

Dec 22
Mithra Pharmaceuticals (EBR:MITRA) Is Making Moderate Use Of Debt

Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates

Nov 24
Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates

Here's Why Mithra Pharmaceuticals (EBR:MITRA) Can Afford Some Debt

Jun 07
Here's Why Mithra Pharmaceuticals (EBR:MITRA) Can Afford Some Debt

When Will Mithra Pharmaceuticals SA (EBR:MITRA) Turn A Profit?

May 10
When Will Mithra Pharmaceuticals SA (EBR:MITRA) Turn A Profit?

Is Mithra Pharmaceuticals SA's (EBR:MITRA) Shareholder Ownership Skewed Towards Insiders?

Mar 18
Is Mithra Pharmaceuticals SA's (EBR:MITRA) Shareholder Ownership Skewed Towards Insiders?

We're Not So Sure You Should Rely on Mithra Pharmaceuticals' (EBR:MITRA) Statutory Earnings

Feb 16
We're Not So Sure You Should Rely on Mithra Pharmaceuticals' (EBR:MITRA) Statutory Earnings

Analysts Expect Breakeven For Mithra Pharmaceuticals SA (EBR:MITRA) Before Long

Jan 21
Analysts Expect Breakeven For Mithra Pharmaceuticals SA (EBR:MITRA) Before Long

Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates

Nov 29
Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates

CEO

Christophe Marechal

7.6yrs

Tenure

Mr. Christophe Maréchal has been the Chief Financial Officer of Mithra Pharmaceuticals SA since February 23, 2017 and also serves as its Co-Chief Executive Officer since March 5, 2024. Mr. Maréchal serves...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Christophe Marechal
Co-CEO & CFO7.6yrsgeen gegevensgeen gegevens
Xavier Paoli
COO & Co-CEOless than a yeargeen gegevensgeen gegevens
Graham Dixon
Chief Scientific Officer5.2yrsgeen gegevensgeen gegevens
Alex Sokolowski
Head of Investor Relationsno datageen gegevensgeen gegevens
Fanny Rozenberg
Secretary of the Board & General Counselno datageen gegevensgeen gegevens
Fanny Storms
Compliance Officerno datageen gegevensgeen gegevens
Frederique Depraetere
Communication Directorno datageen gegevensgeen gegevens
Catherine Lejeune
HR Directorno datageen gegevensgeen gegevens
Jean-Manuel Fontaine
Chief Business Officer3.7yrsgeen gegevens0.000040%
€ 4.9
Jean-Michel Foidart
President of the Scientific Advisory Board & Executive Directorno data€7.12k0.029%
€ 3.6k
Christophe Saillez
Head of Global Regulatory Affairsno datageen gegevensgeen gegevens
Maud Jost
Head of Program & Project Managementno datageen gegevensgeen gegevens

4.4yrs

Gemiddelde duur

Ervaren management: Het managementteam van MITRA wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.4 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Jean-Michel Foidart
President of the Scientific Advisory Board & Executive Director8yrs€7.12k0.029%
€ 3.6k
Jacques Platieau
Independent & Non-Executive Director1.7yrs€25.00kgeen gegevens
Valerie Gordenne
Non-Executive Director2.8yrs€20.00k0.042%
€ 5.1k

2.8yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van MITRA wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 2.8 jaar), wat duidt op een nieuw bestuur.